SE9103837D0 - Fluorescensdiagnostik av cancer utnyttjande delta-aminolevulinsyra - Google Patents

Fluorescensdiagnostik av cancer utnyttjande delta-aminolevulinsyra

Info

Publication number
SE9103837D0
SE9103837D0 SE9103837A SE9103837A SE9103837D0 SE 9103837 D0 SE9103837 D0 SE 9103837D0 SE 9103837 A SE9103837 A SE 9103837A SE 9103837 A SE9103837 A SE 9103837A SE 9103837 D0 SE9103837 D0 SE 9103837D0
Authority
SE
Sweden
Prior art keywords
tissue
cancer
delta
fluorescense
diagnosis
Prior art date
Application number
SE9103837A
Other languages
English (en)
Other versions
SE9103837L (sv
Inventor
Jonas Johansson
Katarina Svanberg
Roger Berg
Sune Svanberg
Original Assignee
Jonas Johansson
Katarina Svanberg
Roger Berg
Sune Svanberg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jonas Johansson, Katarina Svanberg, Roger Berg, Sune Svanberg filed Critical Jonas Johansson
Priority to SE9103837A priority Critical patent/SE9103837L/sv
Publication of SE9103837D0 publication Critical patent/SE9103837D0/sv
Priority to PCT/SE1992/000879 priority patent/WO1993013403A1/en
Publication of SE9103837L publication Critical patent/SE9103837L/sv
Priority to EP19930901458 priority patent/EP0588994A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/001Preparation for luminescence or biological staining
    • A61K49/0013Luminescence
    • A61K49/0017Fluorescence in vivo
    • A61K49/0019Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A61B5/0071Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence by measuring fluorescence emission
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A61B5/0075Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence by spectroscopy, i.e. measuring spectra, e.g. Raman spectroscopy, infrared absorption spectroscopy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A61B5/0082Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes
    • A61B5/0084Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes for introduction into the body, e.g. by catheters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A61B5/0082Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes
    • A61B5/0091Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes for mammography
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/43Detecting, measuring or recording for evaluating the reproductive systems
    • A61B5/4306Detecting, measuring or recording for evaluating the reproductive systems for evaluating the female reproductive systems, e.g. gynaecological evaluations
    • A61B5/4312Breast evaluation or disorder diagnosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SE9103837A 1991-12-21 1991-12-21 Fluorescensdiagnostik av cancer utnyttjande delta- aminolevulinsyra SE9103837L (sv)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SE9103837A SE9103837L (sv) 1991-12-21 1991-12-21 Fluorescensdiagnostik av cancer utnyttjande delta- aminolevulinsyra
PCT/SE1992/000879 WO1993013403A1 (en) 1991-12-21 1992-12-18 FLUORESCENCE DIAGNOSTICS OF CANCER USING δ-AMINO LEVULINIC ACID
EP19930901458 EP0588994A1 (en) 1991-12-21 1993-07-19 FLUORESCENCE DIAGNOSTICS OF CANCER USING $g(d)-AMINO LEVULINIC ACID

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9103837A SE9103837L (sv) 1991-12-21 1991-12-21 Fluorescensdiagnostik av cancer utnyttjande delta- aminolevulinsyra

Publications (2)

Publication Number Publication Date
SE9103837D0 true SE9103837D0 (sv) 1991-12-21
SE9103837L SE9103837L (sv) 1993-06-22

Family

ID=20384715

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9103837A SE9103837L (sv) 1991-12-21 1991-12-21 Fluorescensdiagnostik av cancer utnyttjande delta- aminolevulinsyra

Country Status (3)

Country Link
EP (1) EP0588994A1 (sv)
SE (1) SE9103837L (sv)
WO (1) WO1993013403A1 (sv)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2226544A1 (en) * 1995-07-12 1997-01-30 Hisao Takayanagi 2,2-dideutero-5-aminolevulinic acid
DE29620732U1 (de) * 1995-09-26 1997-04-24 Storz Karl Gmbh & Co Vorrichtung zur photodynamischen Diagnose
ZA967500B (en) * 1995-12-21 1998-03-05 Unilever Plc Device for the identification of acne, microcomedones, and bacteria on human skin.
DE19618963C5 (de) * 1996-05-10 2004-01-22 Stepp, Herbert, Dr. Zusatzvorrichtung für ein Endoskop und Verfahren zur endoskopischen Erfassung von Fluoreszenzlicht unter Verwendung derselben
SE507490C2 (sv) * 1996-08-27 1998-06-15 Medeikonos Ab Förfarande för detektering av cancer i hud på människor och däggdjur samt anordning för utövande av förfarandet
US6989140B2 (en) 2001-12-21 2006-01-24 Threshold Pharmaceuticals, Inc. Methods for cancer imaging
WO2004083944A2 (en) 2003-03-18 2004-09-30 The General Hospital Corporation Polarized light devices and methods
WO2005027730A2 (en) 2003-09-19 2005-03-31 The General Hospital Corporation Fluorescence polarization imaging devices and methods
CZ301399B6 (cs) * 2004-09-03 2010-02-17 Stabilizacní disperzní základ pro fotodynamickou diagnostiku a terapii
EP1742038A1 (en) * 2005-07-06 2007-01-10 Academisch Medisch Centrum bij de Universiteit van Amsterdam Device and method for determining the concentration of a substance
EP2318823B1 (en) 2008-08-15 2015-12-02 Erasmus University Medical Center Rotterdam Methods and devices for assessment of mitochondrial function
KR20140039030A (ko) * 2011-06-29 2014-03-31 교토후고리츠다이가쿠호진 종양 부위의 식별 장치 및 식별 방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE455646B (sv) * 1984-10-22 1988-07-25 Radians Innova Ab Fluorescensanordning
GB2203831B (en) * 1986-07-07 1991-02-06 Academy Of Applied Sciences Apparatus and method for the diagnosis of malignant tumours
SE8900612D0 (sv) * 1989-02-22 1989-02-22 Jonas Johansson Vaevnadskarakterisering utnyttjande ett blodfritt fluorescenskriterium
US5079262A (en) * 1989-07-28 1992-01-07 Queen's University At Kingston Method of detection and treatment of malignant and non-malignant lesions utilizing 5-aminolevulinic acid

Also Published As

Publication number Publication date
WO1993013403A1 (en) 1993-07-08
EP0588994A1 (en) 1994-03-30
SE9103837L (sv) 1993-06-22

Similar Documents

Publication Publication Date Title
Dougherty et al. Photoradiation therapy—clinical and drug advances
SE9103837D0 (sv) Fluorescensdiagnostik av cancer utnyttjande delta-aminolevulinsyra
ATE194916T1 (de) Intraoperative, intravaskulare und endoskopische bestimmung und behandlung von verletzungen und tumoren
FI923743A0 (fi) Med ultraljud effektiverat foerfarande foer levererande av materialer genom huden.
Kessel et al. Porphyrin accumulation by atheromatous plaques of the aorta
FI955336A (sv) Tricyklopolyazamakrocyklofosfonsyror, komplex och derivat därav för användning som kontrasmedel
FI955319A0 (sv) 2-pyridylmetylenpolyazamakrocyklofosfonsyror, komplexer och derivat av dessa för användning som kontrastmedel
EA200401410A1 (ru) Фармацевтическая композиция
DE69014137D1 (de) Immunogenische Zusammensetzungen gegen Gastrin-Peptide.
CY1106860T1 (el) Δομες χρωστικων ευαισθητες σε οξεα και διασπωμενες ενζυμικα για τη διαγνωστικη με ακτινοβολια εγγυς υπερυθρου και για τη θεραπεια
EA199900695A1 (ru) Проникновение анестезирующих средств для местного воздействия, осуществляемое с помощью лазера
ATE7856T1 (de) Gamma-linolensaeuren enthaltende pharmazeutische und diaetetische zusammensetzung.
DE69813553D1 (de) Anwendung von akustooptischen und sonolumineszenten kontrastmitteln in diagnostischen verfahren
NZ334191A (en) Method for improved selectivity in photo-activation and detection of molecular diagnostic agents
PT1157041E (pt) Anticorpos para terapia e diagnostico de cancro
RU92016479A (ru) Применение 5,10,15,20-тетракис (4-карбоксифенил) порфина для обнаружения и лечения рака легких
DE69826711D1 (de) Verfahren zur behandlung von pigmentierten krebszellen durch photodynamische therapie
IT8021498A0 (it) Sali misti di amminoacidi essenziali o semi-essenziali e loro analoghi non azotati, nonche' loro impiego nella terapia di disfunzioni renali ed epatiche.
FR2373599A1 (fr) Luminophore perfectionne a base d'oxyhalogenure de terres-rares
ATE161419T1 (de) Kosmetische zusammensetzung, die einen lipidstoff und eine hydroxy - oder ketofettsäure enthält
SE8401537D0 (sv) Forbettrade analgetiska och anti-inflammatoriska kompositioner innefattande ibuprofen och sett att anvenda dessa
DE3484198D1 (de) Verfahren zur erhoehung der zielspezifizitaet in antikoerperbestimmungen und zur raeumung von nichtzielspezifischen diagnostischen und therapeutischen faktoren.
FI895141A0 (fi) Kelatmedel med orto-ligerande funktionalitet och deras komplexer.
SE7902742L (sv) Disubstituerade 3-cefem-4-karboxylsyraderivat samt forfarande for framstellning derav
FI913391A0 (fi) Foerfarande foer detektering av smaocellcarcinom och anvaendning av acylpeptidhydrolas och denna kodande sekvenser.

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 9103837-2

Format of ref document f/p: F